These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 14682232)

  • 1. [Anti-citrulline antibodies in rheumatoid arthritis; diagnostic and prognostic values].
    Szmyrka-Kaczmarek M; Dziemianko I; Szechiński J
    Pol Arch Med Wewn; 2003 Aug; 110(2):915-20. PubMed ID: 14682232
    [No Abstract]   [Full Text] [Related]  

  • 2. Anti-cyclic citrullinated peptide antibodies as a diagnostic test for rheumatoid arthritis and predictor of an erosive disease.
    Orbach H; Gilburd B; Brickman CM; Gerli R; Shoenfeld Y
    Isr Med Assoc J; 2002 Nov; 4(11 Suppl):892-3. PubMed ID: 12455175
    [No Abstract]   [Full Text] [Related]  

  • 3. [Anticitrulline antibodies - new marker in rheumatoid arthritis diagnostics].
    Kirdaite G; Redaitiene E; Dadoniene J; Stropuviene S
    Medicina (Kaunas); 2003; 39(5):435-7. PubMed ID: 12794363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide.
    Schellekens GA; Visser H; de Jong BA; van den Hoogen FH; Hazes JM; Breedveld FC; van Venrooij WJ
    Arthritis Rheum; 2000 Jan; 43(1):155-63. PubMed ID: 10643712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Value of anti-cyclic citrullinated peptides antibodies in comparison with rheumatoid factor for rheumatoid arthritis diagnosis].
    Dubrous P; Gardet V; Hugard L
    Pathol Biol (Paris); 2005 Mar; 53(2):63-7. PubMed ID: 15708648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic value of anti-modified citrullinated vimentin in rheumatoid arthritis.
    Maraina CH; Nurdayana AK; Rusni D; Azwany Y
    Int J Rheum Dis; 2010 Oct; 13(4):335-9. PubMed ID: 21199468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-cyclic citrullinated peptide antibody in early rheumatoid arthritis: comment on the editorial by Scott.
    van Venrooij WJ; van de Putte LB; van den Hoogen FH
    Arthritis Rheum; 2003 Mar; 48(3):857; author reply 857-8. PubMed ID: 12632446
    [No Abstract]   [Full Text] [Related]  

  • 8. Association of anti-cyclic citrullinated peptide antibodies, anti-citrullin antibodies, and IgM and IgA rheumatoid factors with serological parameters of disease activity in rheumatoid arthritis.
    Greiner A; Plischke H; Kellner H; Gruber R
    Ann N Y Acad Sci; 2005 Jun; 1050():295-303. PubMed ID: 16014545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibodies against transglutaminases, peptidylarginine deiminase and citrulline in rheumatoid arthritis--new pathways to epitope spreading.
    Roth EB; Stenberg P; Book C; Sjöberg K
    Clin Exp Rheumatol; 2006; 24(1):12-8. PubMed ID: 16539813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies to citrullinated human fibrinogen (ACF) have diagnostic and prognostic value in early arthritis.
    Nielen MM; van der Horst AR; van Schaardenburg D; van der Horst-Bruinsma IE; van de Stadt RJ; Aarden L; Dijkmans BA; Hamann D
    Ann Rheum Dis; 2005 Aug; 64(8):1199-204. PubMed ID: 15640269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rheumatoid factors from patients with rheumatoid arthritis react with beta 2-microglobulin.
    Williams RC; Malone CC; Tsuchiya N
    Trans Am Clin Climatol Assoc; 1993; 104():198-212; discussion 212-3. PubMed ID: 1285310
    [No Abstract]   [Full Text] [Related]  

  • 12. Superior specificity of anti-citrullinated peptide antibodies in patients with chronic lymphocytic leukemia and arthritis.
    Brickmann K; Brezinschek RI; Yazdani-Biuki B; Graninger WB; Brezinschek HP
    Clin Exp Rheumatol; 2010; 28(6):888-91. PubMed ID: 21205465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-CCP2 is an adjunct to, not a surrogate for, rheumatoid factor in the diagnosis of rheumatoid arthritis: diagnostic utility of anti-CCP2 antibodies in Egyptian patients with rheumatoid arthritis.
    Abdel-Nasser AM; Mahmoud MH; El Mansoury TM; Osman AM
    Scand J Rheumatol; 2008; 37(5):329-36. PubMed ID: 18666028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-cyclic citrullinated peptide positivity in non-rheumatoid arthritis disease samples: citrulline-dependent or not?
    Vannini A; Cheung K; Fusconi M; Stammen-Vogelzangs J; Drenth JP; Dall'Aglio AC; Bianchi FB; Bakker-Jonges LE; van Venrooij WJ; Pruijn GJ; Zendman AJ
    Ann Rheum Dis; 2007 Apr; 66(4):511-6. PubMed ID: 16984940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specificity of rheumatoid factors in relation to the disease state in rheumatoid arthritis.
    Jones MG; Shipley ME; Hearn JP; Hay FC
    Ann Rheum Dis; 1990 Oct; 49(10):757-62. PubMed ID: 2241264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prevalence and significance of antibodies to citrullinated human fibrinogen β67-77 peptide in rheumatoid arthritis].
    Li GY; Sun XL; An Y; Hu FL; Li Y; Li ZG
    Zhonghua Yi Xue Za Zhi; 2013 Sep; 93(33):2642-5. PubMed ID: 24360044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An investigation of the added value of an ACPA multiplex assay in an early rheumatoid arthritis setting.
    van Heemst J; Trouw LA; Nogueira L; van Steenbergen HW; van der Helm-van Mil AH; Allaart CF; Serre G; Holmdahl R; Huizinga TW; Toes RE; van der Woude D
    Arthritis Res Ther; 2015 Oct; 17():276. PubMed ID: 26437716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-CCP antibodies: the new rheumatoid factor in the serology of rheumatoid arthritis.
    van Venrooij WJ; Vossenaar ER; Zendman AJ
    Autoimmun Rev; 2004 Jun; 3 Suppl 1():S17-9. PubMed ID: 15309772
    [No Abstract]   [Full Text] [Related]  

  • 19. The diagnosis and prognosis of early arthritis: comment on the editorial by Scott.
    Visser H; Hazes JM
    Arthritis Rheum; 2003 Mar; 48(3):856-7; author reply 857-8. PubMed ID: 12632444
    [No Abstract]   [Full Text] [Related]  

  • 20. Anti-cyclic citrullinated antibodies: complementary to IgM rheumatoid factor in the early diagnosis of rheumatoid arthritis.
    Solanki K; Spellerberg M; Chapman P; Moller P; O'Donnell J
    N Z Med J; 2004 Oct; 117(1203):U1097. PubMed ID: 15477921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.